Company
United StatesPublic company, NASDAQ: REGNRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Rensselaer, NY – FDA Inspections
Inspection records and compliance data for Regeneron Pharmaceuticals, Inc. in Rensselaer, NY. Access full analysis and detailed observations. Publicly traded as NASDAQ: REGN.
Company Profile
This profile covers Regeneron Pharmaceuticals, Inc. based in Rensselaer, NY, United States.
FDA documents
Other FDA documents (4)
Other regulators (1)
- Health Canada · 7 inspections · last March 13, 2024
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Regeneron Pharmaceuticals, Inc.
Stock ticker
REGN
Exchange
NASDAQ
Share price
$951.19
Market cap
$98.4B
Price as of
November 13, 2026
Address
81 Columbia Turnpike, Rensselaer, NY 12144, United States
Country
United States
ID: 1a313867-ad13-4575-9bfb-473f021b19db